|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Gain on sale of division | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Unrealized mark-to-market gain on derivative contracts | |||||
| Bad debt expense (recovery), net | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Contract assets and liabilities, net | |||||
| Inventories | |||||
| Income taxes | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Investing Activities: | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Proceeds from sale of division | |||||
| Cash paid for business acquisition, net of cash acquired | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from life insurance policy | |||||
| Purchase of intangible assets | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Payments on industrial development revenue bonds | |||||
| Shares withheld in lieu of employee tax withholding | |||||
| Dividends paid | |||||
| Net cash used in financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...